Merck (MRK) Finished Goods (2009 - 2012)

Merck (MRK) reported Finished Goods of $1.8 billion for Q2 2012, up 25.56% year-over-year from $1.4 billion in Q3 2011, and up 1.63% quarter-over-quarter from $1.8 billion in Q1 2012.

Merck (MRK) Finished Goods (2009 - 2012) Analysis & Trends

Merck (MRK) has 4 years of Finished Goods data on file, last reported at $1.8 billion in Q2 2012.

  • Finished Goods for Q2 2012 came in at $1.8 billion, up 25.56% year-over-year; the trailing twelve-month figure through Jun 2012 was $1.8 billion (up 25.56% YoY), and the FY2011 annual result was $2.0 billion, up 33.63% from the prior year.
  • Finished Goods advanced to $1.8 billion in Q2 2012 per MRK's latest filing, from $1.8 billion in the prior quarter.
  • Over five years, Finished Goods peaked at $2.5 billion in Q4 2009 and troughed at $1.4 billion in Q1 2011.
  • A 4-year average of $1.8 billion and a median of $1.8 billion in 2012 frame the typical range for Finished Goods.
  • The sharpest annual moves came in 2010 and 2011: Finished Goods tumbled 39.82% in 2010, then jumped 33.63% in 2011.
  • A 4-year view of Finished Goods shows it stood at $2.5 billion in 2009, then plunged by 39.82% to $1.5 billion in 2010, then soared by 33.63% to $2.0 billion in 2011, then dropped by 8.83% to $1.8 billion in 2012.
  • Business Quant data shows MRK's Finished Goods at $1.8 billion in Q2 2012, $1.8 billion in Q1 2012, and $2.0 billion in Q4 2011.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Gsk 93,699,046.73 Bn 93,699,041.77 Bn 7.76 Bn
2 Eli Lilly 1,012.06 Bn 1,006.77 Bn 16.22 Bn
3 Johnson & Johnson 560.67 Bn 538.62 Bn 15.96 Bn
4 AbbVie 402.20 Bn 392.85 Bn 10.78 Bn
5 Merck 298.59 Bn 292.94 Bn 12.09 Bn
6 Amgen 188.77 Bn 176.74 Bn 5.87 Bn
7 Gilead Sciences 160.22 Bn 152.49 Bn 5.52 Bn
8 Pfizer 148.19 Bn 135.42 Bn -1.21 Bn
9 Bristol Myers Squibb 116.72 Bn 106.26 Bn 8.07 Bn
10 Novartis Ag 109.78 Bn 109.09 Bn -

Historic Data

Download Data
DateValue
Jun 30, 2012 1.81 Bn
Mar 31, 2012 1.78 Bn
Dec 31, 2011 1.98 Bn
Sep 30, 2011 1.64 Bn
Jun 30, 2011 1.44 Bn
Mar 31, 2011 1.38 Bn
Dec 31, 2010 1.48 Bn
Sep 30, 2010 1.95 Bn
Jun 30, 2010 1.88 Bn
Dec 31, 2009 2.47 Bn